{"title":"네이버 금융 ─ 뉴스 ─ 기업 종목분석","url":"https://finance.naver.com/news/news_list.naver?mode=LSS3D&section_id=101&section_id2=258&section_id3=402","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"오미크론 이후 달라진 장바구니…서학개미 \"레버리지 베팅\"","contents":"<a href=\"/news/news_read.naver?article_id=0005012202&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1\" title=\"오미크론 이후 달라진 장바구니…서학개미 &quot;레버리지 베팅&quot;\">오미크론 이후 달라진 장바구니…서학개미 \"레버리지 베팅\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0005012202&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211208&page=1","retrieved":1638932736703},{"title":"연말 배당주 투자 \"만족스럽지는 않네\"…수익률 작년보다 '저조'","contents":"<a href=\"/news/news_read.naver?article_id=0005012198&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1\" title=\"연말 배당주 투자 &quot;만족스럽지는 않네&quot;…수익률 작년보다 '저조'\">연말 배당주 투자 \"만족스럽지는 않네\"…수익률 작년보다 '저조'</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0005012198&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211208&page=1","retrieved":1638932736703},{"title":"NFT 관련주 뒤늦게 뛰어드는 개인…물량 넘기는 외인·기관","contents":"<a href=\"/news/news_read.naver?article_id=0005012178&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1\" title=\"NFT 관련주 뒤늦게 뛰어드는 개인…물량 넘기는 외인·기관\">NFT 관련주 뒤늦게 뛰어드는 개인…물량 넘기는 외인·기관</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0005012178&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211208&page=1","retrieved":1638932736709},{"title":"제넨셀, 경구용 코로나 치료제 특허 출원...\"오미크론 치료 기대\"","contents":"<a href=\"/news/news_read.naver?article_id=0004680685&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1\" title=\"제넨셀, 경구용 코로나 치료제 특허 출원...&quot;오미크론 치료 기대&quot;\">제넨셀, 경구용 코로나 치료제 특허 출원...\"오미크론 치료 기대\"</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004680685&office_id=008&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211208&page=1","retrieved":1638932736709},{"title":"액션스퀘어, 앤빌 매치 연다…소우릎·인간젤리 등 참여","contents":"<a href=\"/news/news_read.naver?article_id=0004680683&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1\" title=\"액션스퀘어, 앤빌 매치 연다…소우릎·인간젤리 등 참여\">액션스퀘어, 앤빌 매치 연다…소우릎·인간젤리 등 참여</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004680683&office_id=008&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211208&page=1","retrieved":1638932736710},{"title":"알파홀딩스, 벨기에 바이오기업 PDC에 75만유로 투자","contents":"<a href=\"/news/news_read.naver?article_id=0004680680&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1\" title=\"알파홀딩스, 벨기에 바이오기업 PDC에 75만유로 투자\">알파홀딩스, 벨기에 바이오기업 PDC에 75만유로 투자</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004680680&office_id=008&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211208&page=1","retrieved":1638930373360},{"title":"[주식초고수는 지금] 뜨거운 가상화폐 열기...다날·비덴트 매수세 몰려","contents":"<a href=\"/news/news_read.naver?article_id=0003994321&amp;office_id=011&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1\" title=\"[주식초고수는 지금] 뜨거운 가상화폐 열기...다날·비덴트 매수세 몰려\">[주식초고수는 지금] 뜨거운 가상화폐 열기...다날·비덴트 매수세 몰려</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0003994321&office_id=011&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211208&page=1","retrieved":1638930373363},{"title":"[2021자본투자대상]NH투자증권, IB부문 최우수상…IPO 흥행 주도","contents":"<a href=\"/news/news_read.naver?article_id=0005012125&amp;office_id=277&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211208&amp;page=1\" title=\"[2021자본투자대상]NH투자증권, IB부문 최우수상…IPO 흥행 주도\">[2021자본투자대상]NH투자증권, IB부문 최우수상…IPO 흥행 주도</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0005012125&office_id=277&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211208&page=1","retrieved":1638930373363}]}